nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—bile duct cancer	0.744	1	CbGaD
Celecoxib—ORM1—bile—bile duct cancer	0.0171	0.22	CbGeAlD
Celecoxib—CA9—gall bladder—bile duct cancer	0.00809	0.104	CbGeAlD
Celecoxib—ORM1—gall bladder—bile duct cancer	0.00475	0.0611	CbGeAlD
Celecoxib—PDPK1—liver—bile duct cancer	0.00432	0.0557	CbGeAlD
Celecoxib—ALB—gall bladder—bile duct cancer	0.00416	0.0536	CbGeAlD
Celecoxib—CA5A—liver—bile duct cancer	0.00406	0.0523	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—bile duct cancer	0.0036	1	CrCbGaD
Celecoxib—PDPK1—lymph node—bile duct cancer	0.00331	0.0427	CbGeAlD
Celecoxib—CA2—gall bladder—bile duct cancer	0.00307	0.0395	CbGeAlD
Celecoxib—CA5B—pancreas—bile duct cancer	0.00247	0.0318	CbGeAlD
Celecoxib—MAPK14—liver—bile duct cancer	0.00231	0.0298	CbGeAlD
Celecoxib—PTGS2—gall bladder—bile duct cancer	0.00227	0.0292	CbGeAlD
Celecoxib—CA14—liver—bile duct cancer	0.00225	0.029	CbGeAlD
Celecoxib—ABCC4—pancreas—bile duct cancer	0.00186	0.0239	CbGeAlD
Celecoxib—MAPK14—lymph node—bile duct cancer	0.00177	0.0228	CbGeAlD
Celecoxib—CA2—pancreas—bile duct cancer	0.00142	0.0182	CbGeAlD
Celecoxib—ORM1—liver—bile duct cancer	0.00139	0.0179	CbGeAlD
Celecoxib—ALB—liver—bile duct cancer	0.00122	0.0157	CbGeAlD
Celecoxib—CA5B—lymph node—bile duct cancer	0.00121	0.0155	CbGeAlD
Celecoxib—ABCC4—liver—bile duct cancer	0.00118	0.0152	CbGeAlD
Celecoxib—ORM1—lymph node—bile duct cancer	0.00107	0.0137	CbGeAlD
Celecoxib—PTGS2—pancreas—bile duct cancer	0.00104	0.0135	CbGeAlD
Celecoxib—ALB—lymph node—bile duct cancer	0.000936	0.012	CbGeAlD
Celecoxib—ABCC4—lymph node—bile duct cancer	0.000906	0.0117	CbGeAlD
Celecoxib—CA2—liver—bile duct cancer	0.0009	0.0116	CbGeAlD
Celecoxib—CA4—lymph node—bile duct cancer	0.000832	0.0107	CbGeAlD
Celecoxib—CYP2C9—liver—bile duct cancer	0.000762	0.00981	CbGeAlD
Celecoxib—CA2—lymph node—bile duct cancer	0.00069	0.00889	CbGeAlD
Celecoxib—PTGS2—liver—bile duct cancer	0.000665	0.00856	CbGeAlD
Celecoxib—CYP3A4—liver—bile duct cancer	0.000581	0.00748	CbGeAlD
Celecoxib—CYP2D6—liver—bile duct cancer	0.000572	0.00736	CbGeAlD
Celecoxib—PTGS2—lymph node—bile duct cancer	0.00051	0.00656	CbGeAlD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—bile duct cancer	0.000141	0.000812	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.000141	0.000812	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	0.000141	0.000811	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—GNAS—bile duct cancer	0.000139	0.000797	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—KRAS—bile duct cancer	0.000137	0.000789	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HGF—bile duct cancer	0.000137	0.000785	CbGpPWpGaD
Celecoxib—MAPK14—MyD88-independent cascade—IL6—bile duct cancer	0.000136	0.000779	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.000135	0.000776	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SLC5A5—bile duct cancer	0.000135	0.000773	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.000133	0.000765	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000133	0.000761	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GNAS—bile duct cancer	0.000131	0.000753	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.00013	0.000743	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC5A5—bile duct cancer	0.000129	0.000741	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—bile duct cancer	0.000128	0.000735	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.000128	0.000732	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000127	0.000729	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—SMAD4—bile duct cancer	0.000126	0.000722	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—HRAS—bile duct cancer	0.000126	0.000722	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—GNAS—bile duct cancer	0.000126	0.000722	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000124	0.000714	CbGpPWpGaD
Celecoxib—ALB—Metabolism—FAR2—bile duct cancer	0.000122	0.000703	CbGpPWpGaD
Celecoxib—MAPK14—Activated TLR4 signalling—IL6—bile duct cancer	0.000122	0.000701	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	0.000122	0.000698	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFBR2—bile duct cancer	0.000121	0.000697	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	0.000121	0.000696	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HGF—bile duct cancer	0.000121	0.000694	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—IL6—bile duct cancer	0.00012	0.000691	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00012	0.00069	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HGF—bile duct cancer	0.00012	0.000688	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—ERBB2—bile duct cancer	0.00012	0.000687	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000119	0.000684	CbGpPWpGaD
Celecoxib—PDPK1—Neuronal System—HRAS—bile duct cancer	0.000119	0.000684	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.000119	0.000684	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.000118	0.000677	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—bile duct cancer	0.000118	0.000676	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—HRAS—bile duct cancer	0.000117	0.00067	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—bile duct cancer	0.000116	0.000664	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000115	0.000663	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SMAD4—bile duct cancer	0.000115	0.00066	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—ERBB2—bile duct cancer	0.000115	0.00066	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—bile duct cancer	0.000115	0.000659	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.000113	0.000646	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—bile duct cancer	0.000112	0.000644	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—IL6—bile duct cancer	0.000112	0.000642	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—TGFB1—bile duct cancer	0.00011	0.000634	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—KRAS—bile duct cancer	0.000109	0.000627	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—ERBB2—bile duct cancer	0.000109	0.000626	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC5A5—bile duct cancer	0.000109	0.000624	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000108	0.000621	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.000108	0.000619	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000106	0.000611	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—bile duct cancer	0.000106	0.000608	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.000105	0.000604	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—bile duct cancer	0.000105	0.000603	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS2—bile duct cancer	0.000105	0.000602	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GNAS—bile duct cancer	0.000105	0.0006	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000104	0.000599	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.000103	0.000594	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	0.000103	0.000593	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—IL6—bile duct cancer	0.000103	0.000589	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.000102	0.000587	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—NRAS—bile duct cancer	0.000101	0.00058	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—FAR2—bile duct cancer	0.000101	0.00058	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GNAS—bile duct cancer	0.0001	0.000576	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—FAR2—bile duct cancer	0.0001	0.000575	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	0.0001	0.000574	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	9.86e-05	0.000566	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	9.83e-05	0.000564	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	9.81e-05	0.000563	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—bile duct cancer	9.71e-05	0.000557	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL6—bile duct cancer	9.7e-05	0.000557	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RNF43—bile duct cancer	9.67e-05	0.000555	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—bile duct cancer	9.66e-05	0.000554	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MET—bile duct cancer	9.64e-05	0.000553	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	9.62e-05	0.000552	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	9.56e-05	0.000549	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	9.53e-05	0.000547	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	9.48e-05	0.000544	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	9.45e-05	0.000542	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—bile duct cancer	9.4e-05	0.000539	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	9.28e-05	0.000533	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS2—bile duct cancer	9.19e-05	0.000527	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NRAS—bile duct cancer	9.11e-05	0.000523	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—bile duct cancer	8.95e-05	0.000514	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RNF43—bile duct cancer	8.83e-05	0.000506	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	8.77e-05	0.000503	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NRAS—bile duct cancer	8.74e-05	0.000502	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—KRAS—bile duct cancer	8.71e-05	0.0005	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS2—bile duct cancer	8.56e-05	0.000491	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFBR2—bile duct cancer	8.51e-05	0.000488	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GNAS—bile duct cancer	8.45e-05	0.000485	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—bile duct cancer	8.36e-05	0.00048	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NRAS—bile duct cancer	8.3e-05	0.000476	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—bile duct cancer	8.3e-05	0.000476	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	8.23e-05	0.000472	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNAS—bile duct cancer	8.21e-05	0.000471	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—bile duct cancer	8.2e-05	0.00047	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—bile duct cancer	8.15e-05	0.000467	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—bile duct cancer	8.15e-05	0.000467	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SMAD4—bile duct cancer	8.05e-05	0.000462	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—bile duct cancer	8.04e-05	0.000461	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—bile duct cancer	7.97e-05	0.000457	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	7.89e-05	0.000453	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KRAS—bile duct cancer	7.84e-05	0.00045	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—bile duct cancer	7.74e-05	0.000444	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	7.71e-05	0.000442	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—bile duct cancer	7.6e-05	0.000436	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IDH1—bile duct cancer	7.59e-05	0.000435	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—bile duct cancer	7.56e-05	0.000434	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	7.55e-05	0.000433	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	7.54e-05	0.000432	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KRAS—bile duct cancer	7.53e-05	0.000432	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—bile duct cancer	7.4e-05	0.000425	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—IDH2—bile duct cancer	7.39e-05	0.000424	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.24e-05	0.000416	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KRAS—bile duct cancer	7.14e-05	0.00041	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—bile duct cancer	7.04e-05	0.000404	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—ERBB2—bile duct cancer	7.04e-05	0.000404	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ERBB2—bile duct cancer	6.97e-05	0.0004	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	6.8e-05	0.00039	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—bile duct cancer	6.77e-05	0.000388	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	6.67e-05	0.000383	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—bile duct cancer	6.66e-05	0.000382	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FAR2—bile duct cancer	6.61e-05	0.000379	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNAS—bile duct cancer	6.5e-05	0.000373	CbGpPWpGaD
Celecoxib—PDPK1—Disease—ERBB2—bile duct cancer	6.44e-05	0.000369	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SMAD4—bile duct cancer	6.44e-05	0.000369	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—bile duct cancer	6.4e-05	0.000367	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—bile duct cancer	6.38e-05	0.000366	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—IDH1—bile duct cancer	6.36e-05	0.000365	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	6.3e-05	0.000362	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—bile duct cancer	6.29e-05	0.000361	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HGF—bile duct cancer	6.28e-05	0.000361	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ERBB2—bile duct cancer	6.22e-05	0.000357	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HGF—bile duct cancer	6.19e-05	0.000355	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—bile duct cancer	6.19e-05	0.000355	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—bile duct cancer	6.07e-05	0.000348	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—bile duct cancer	6.04e-05	0.000347	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NRAS—bile duct cancer	6e-05	0.000345	CbGpPWpGaD
Celecoxib—ALB—Metabolism—IDH2—bile duct cancer	5.98e-05	0.000343	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—bile duct cancer	5.81e-05	0.000333	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NRAS—bile duct cancer	5.81e-05	0.000333	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.63e-05	0.000323	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—bile duct cancer	5.62e-05	0.000322	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	5.6e-05	0.000321	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—bile duct cancer	5.58e-05	0.00032	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—bile duct cancer	5.39e-05	0.000309	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NRAS—bile duct cancer	5.36e-05	0.000307	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NRAS—bile duct cancer	5.3e-05	0.000304	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—bile duct cancer	5.29e-05	0.000303	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NRAS—bile duct cancer	5.26e-05	0.000302	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—KRAS—bile duct cancer	5.17e-05	0.000297	CbGpPWpGaD
Celecoxib—ALB—Metabolism—IDH1—bile duct cancer	5.14e-05	0.000295	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—KRAS—bile duct cancer	5e-05	0.000287	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—bile duct cancer	4.98e-05	0.000286	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—IDH2—bile duct cancer	4.94e-05	0.000283	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	4.9e-05	0.000281	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NRAS—bile duct cancer	4.9e-05	0.000281	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—IDH2—bile duct cancer	4.89e-05	0.000281	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—bile duct cancer	4.88e-05	0.00028	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—bile duct cancer	4.88e-05	0.00028	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—bile duct cancer	4.83e-05	0.000277	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—bile duct cancer	4.75e-05	0.000272	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NRAS—bile duct cancer	4.73e-05	0.000272	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—KRAS—bile duct cancer	4.61e-05	0.000265	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—bile duct cancer	4.59e-05	0.000264	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KRAS—bile duct cancer	4.57e-05	0.000262	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—bile duct cancer	4.55e-05	0.000261	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—bile duct cancer	4.54e-05	0.000261	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—KRAS—bile duct cancer	4.52e-05	0.00026	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB2—bile duct cancer	4.51e-05	0.000259	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—bile duct cancer	4.46e-05	0.000256	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFBR2—bile duct cancer	4.42e-05	0.000254	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—bile duct cancer	4.39e-05	0.000252	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—bile duct cancer	4.31e-05	0.000247	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNAS—bile duct cancer	4.26e-05	0.000245	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—bile duct cancer	4.25e-05	0.000244	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—IDH1—bile duct cancer	4.25e-05	0.000244	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KRAS—bile duct cancer	4.21e-05	0.000242	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—IDH1—bile duct cancer	4.21e-05	0.000242	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC5A5—bile duct cancer	4.19e-05	0.000241	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMAD4—bile duct cancer	4.18e-05	0.00024	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KRAS—bile duct cancer	4.07e-05	0.000234	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—bile duct cancer	4.06e-05	0.000233	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFBR2—bile duct cancer	4.03e-05	0.000231	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—bile duct cancer	4.02e-05	0.000231	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—bile duct cancer	3.92e-05	0.000225	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—bile duct cancer	3.88e-05	0.000223	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—bile duct cancer	3.87e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—bile duct cancer	3.85e-05	0.000221	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SMAD4—bile duct cancer	3.82e-05	0.000219	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—bile duct cancer	3.75e-05	0.000215	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—bile duct cancer	3.71e-05	0.000213	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB2—bile duct cancer	3.62e-05	0.000208	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—bile duct cancer	3.58e-05	0.000206	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—bile duct cancer	3.46e-05	0.000199	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRAS—bile duct cancer	3.43e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—bile duct cancer	3.43e-05	0.000197	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC5A5—bile duct cancer	3.39e-05	0.000195	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—bile duct cancer	3.31e-05	0.00019	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNAS—bile duct cancer	3.26e-05	0.000187	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—IDH2—bile duct cancer	3.23e-05	0.000185	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—bile duct cancer	3.19e-05	0.000183	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.18e-05	0.000182	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—bile duct cancer	3.12e-05	0.000179	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KRAS—bile duct cancer	2.95e-05	0.000169	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—bile duct cancer	2.84e-05	0.000163	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC5A5—bile duct cancer	2.8e-05	0.000161	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC5A5—bile duct cancer	2.78e-05	0.000159	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—IDH1—bile duct cancer	2.78e-05	0.000159	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRAS—bile duct cancer	2.76e-05	0.000158	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NRAS—bile duct cancer	2.72e-05	0.000156	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNAS—bile duct cancer	2.64e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—bile duct cancer	2.62e-05	0.000151	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.6e-05	0.000149	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—bile duct cancer	2.52e-05	0.000145	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—bile duct cancer	2.51e-05	0.000144	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—bile duct cancer	2.51e-05	0.000144	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—bile duct cancer	2.4e-05	0.000138	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—bile duct cancer	2.37e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB2—bile duct cancer	2.34e-05	0.000134	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—bile duct cancer	2.34e-05	0.000134	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNAS—bile duct cancer	2.18e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNAS—bile duct cancer	2.16e-05	0.000124	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB2—bile duct cancer	2.14e-05	0.000123	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—bile duct cancer	2.08e-05	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—bile duct cancer	2.02e-05	0.000116	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—bile duct cancer	2.01e-05	0.000115	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—bile duct cancer	1.99e-05	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—bile duct cancer	1.93e-05	0.000111	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC5A5—bile duct cancer	1.83e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRAS—bile duct cancer	1.78e-05	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—bile duct cancer	1.66e-05	9.5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRAS—bile duct cancer	1.63e-05	9.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—bile duct cancer	1.62e-05	9.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—bile duct cancer	1.53e-05	8.8e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—bile duct cancer	1.51e-05	8.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—bile duct cancer	1.48e-05	8.5e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNAS—bile duct cancer	1.42e-05	8.17e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—bile duct cancer	1.42e-05	8.12e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—bile duct cancer	1.4e-05	8.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—bile duct cancer	1.36e-05	7.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—bile duct cancer	1.3e-05	7.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—bile duct cancer	1.25e-05	7.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—bile duct cancer	1.19e-05	6.82e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—bile duct cancer	1.17e-05	6.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—bile duct cancer	1.16e-05	6.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—bile duct cancer	1.14e-05	6.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—bile duct cancer	7.64e-06	4.39e-05	CbGpPWpGaD
